Skip to main content
FinSpry Logo
FinSpry
RXRX logo
RXRX
(NASDAQ)
Recursion Pharmaceuticals, Inc.
$3.01-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Recursion Pharmaceuticals (RXRX) Stock Price & Financial Analysis

Recursion Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$2.92 - $3.03
52-Week High$7.18
52-Week Low$2.77
Open$2.93
Volume18.77M
Average Volume (3M)22.76M
Market Cap1.59B
Shares Outstanding529.30M
Price to Sales (P/S)24.10
Price to Book (P/B)1.55
EV/EBITDA-2.11
Revenue (TTM)66.10M
Net Income (TTM)-559.78M
Free Cash Flow (TTM)-325.85M
EPS (TTM)$-1.17
Profit Margin-846.92%
Operating Margin-885.48%
Return on Equity (ROE)-54.62%
Debt to Equity0.07
50-Day MA$3.30
200-Day MA$3.99
52-Week Change-53.19%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Recursion Pharmaceuticals

What is the current stock price for RXRX?

As of the latest trading session, RXRX stock trades at $3.01. The 52-week range is $2.77–$7.18, with a day range of $2.92–$3.03.

What is the P/E ratio for RXRX?

The P/E ratio (Price-to-Earnings) for RXRX is shown in the Key Statistics section. This valuation metric helps compare Recursion Pharmaceuticals, Inc. to industry peers.

Does RXRX pay dividends?

Recursion Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for RXRX?

Based on 7 analysts, the consensus for RXRX is Buy.

What is the market cap of RXRX?

Recursion Pharmaceuticals's market capitalization is $1.59B, classifying it as a small-cap company. Recursion Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.